About
Sovargen develops RNA therapeutics and innovative medicines targeting incurable neurological disorders caused by brain somatic mosaicism using proprietary low-frequency mutation detection and brain disease-specific translational research platforms.
Explore 소바젠㈜ / Sovargen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.